Dietary supplement company agrees to fine

Sunrise Nutraceuticals is barred from making claims about health-related products without competent and reliable scientific evidence, the Federal Trade Commission said. The dietary supplement company must pay $235,000 to settle accusations that it made false and misleading claims concerning Elimidrol, a product that is used to alleviate symptoms of opiate